icolung

icometrix

icolung is a cloud-based AI software to quantify the degree of lung involvement in COVID-19 patients. CE cleared, in the US available for clinical use during public health emergency related to COVID-19.

icolung provides the quantification of lung pathology in COVID-19 patients.
- Automated quantification
- Assessment of lesion burden
- Total and regional volumetrics in 6 pulmonary regions
- Quantification per type of CT finding (e.g. GGO, …)

Information source: Vendor
Last updated: June 9, 2024

General Information

General
Product name	icolung
Company	icometrix
Subspeciality	Chest
Modality	CT
Disease targeted	COVID-19
Key-features	Quantification of lung involvement, total and lobular, lesion classification
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion

Technical Specifications

Data characteristics
Population	All non-contrast chest CT images
Input	non-contrast chest CT image
Input format	DICOM
Output	Color-coded segmentation overlays, report with quantification of lung involvement.
Output format	DICOM
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment	Cloud-based
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	1 - 10 minutes

Regulatory

Certification
CE	Certified, Class I , MDD
FDA	No or not yet
Intended Use Statements
Intended use (according to CE)	icobrain ct is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of computed tomography (CT) images. This software is intended to automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on CT images. The software can also be used to perform image processing, analysis, and communication of computed tomography perfusion (CTP) scans of the brain.

Market

Market presence
On market since	04-2020
Distribution channels	Siemens Teamplay, Calantic
Countries present (clinical, non-research use)	17
Paying clinical customers (institutes)	75
Research/test users (institutes)	20
Pricing
Pricing model	Pro bono
Based on	Public need

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers	https://icometrix.com/resources/the-role-of-imaging-ai--and--ct-in-covid19